tirzepatide bruising easily Does Zepbound Cause Bruising? Side Effects Explained 💉So you got a bruise

Sudden cardiac death A total of 85 SCD events and 8 per 10,000 patient-years SCD incidence in GLP-1 RAs group were reported

What the Research Says About Microdose Tirzepatide Here is the honest state of published evidence on subtherapeutic tirzepatide as of 2026: SURMOUNT-1 (tirzepatide 5/10/15 mg, 72 weeks): mean body-weight loss of 15.0%, 19.5%, and 22.5% vs

201, pp

Cardiovascular symptoms such as increased heart rate have been observed with GLP-1 receptor agonists

Epithelial and intestinal models: KPV has been studied in mouse models of colitis and in research involving epithelial inflammatory responses

This highlights the importance of regularly monitoring B12 levels in patients on GLP-1 therapy, especially those with conditions that might worsen B12 absorption, such as digestive disorders